Zuventus Healthcare Limited, Mumbai

The journey of Zuventus Healthcare began in 2002 when a visionary with pharmaceutical expertise instituted a pharma venture for developing therapeutic products that would improve people’s health, aid faster recovery, and empower them to lead quality lives. The mainstays of this concept were – paramount emphasis on quality, ethics, compliance to standards in operations, and making affordable medicines. A concept whose foundations were as strong as these and which was driven by an unshakeable conviction to care for life inevitably reaches its goal. From 400 employees in 2002 to 3000+ employees today, Zuventus Healthcare is the fastest growing pharma company in India with effective and robust product lines covering a range of therapeutic segments including anti-infectives, vitamins/minerals/nutrients, respiratory generics, gastrointestinal, cardiac, gynaecological, pain/analgesic, antidiabetic, cephalosporins and more available in multiple dosages forms such as tablets, capsules, injectables, and liquids. Zuventus has strong manufacturing capabilities based in Jammu, Sikkim, and Bengaluru as well as a DSIR-approved, advanced formulation R & D centre in Pune. Zuventus’s stupendous growth is evident from the fact that – the company crossed the “100-crore” mark in April 2006, the “200-crore” mark in September 2007 and were quick to achieve a turnover of 2000 crores in 20 years. Today, the company is ranked 7th in the directly covered market and overall ranked 23rd amongst the leading pharmaceutical companies in India. As we propel ahead, we will continue to push the boundaries, invest in research and technology to develop drugs and vaccines for improving patients’ wellbeing.

Anthem Biosciences Limited

Anthem Biosciences, a Bangalore-India based Contract Research Development Organization (CDMO) Anthem Bio offers a whole gamut of services dedicated to enabling and sustaining global research efforts in the discovery of new compounds by pharmaceutical, biotechnology, specialty chemicals, agriculture chemicals and material science companies. Anthem's core competencies are organic synthesis, process development, analytical chemistry, discovery biology and regulatory compliance. Anthem works extensively with pharma leaders, mid-size to virtual companies across the globe.

Jubilant Generics Limited

We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc.

Sai Life Sciences Ltd

Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.

Morepen Laboratories Limited India

Morepen is a market leader in glucometers, having installed over 12 million units to date and sold nearly 1.6 million blood glucose strips, driven by an aggressive market expansion strategy into tier-2 and tier-3 cities. As a leading manufacturer of BP monitors, the company has shown impressive growth in the Point of Care (POC) diagnostics segment. In the API business, Morepen holds a leadership position in the export of six key API products: Loratadine, Montelukast, Desloratadine, Atorvastatin, and Fexofenadine, catering to numerous international markets and exporting to over 80 countries. Approximately 68% of Morepen's API products are exported, highlighting its extensive global reach. The company has demonstrated consistent growth in both its top and bottom lines through strategic investments and market expansions. Morepen maintains a debt-free status with robust financials and a negligible interest burden, underscoring its financial stability. Founded in 1984, Morepen Laboratories Limited (www.morepen.com) has established itself as a prominent leader in the pharmaceutical industry, renowned for its high-quality products and innovative solutions. The company offers a diverse range of products, including active pharmaceutical ingredients, diagnostics, and over-the-counter items. Morepen is dedicated to enhancing global health through its advanced research and development efforts.